The landscape of dementia analysis has progressed considerably with the advent of subtle biomarkers, which includes amyloid PET scans, tau imaging, and blood-centered exams which will detect Alzheimer's pathology years just before indications emerge. Although these technological advancements represent exceptional development in being familiar with